Survey
* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
Egyptian Journal of Medical Microbiology Volume 24 / No. 4 / October 2015 35-40 ORIGINAL ARTICLE The Sialic Acid Binding Adhesin (SabA) of Helicobacter pylori Isolated from Egypt is Associated with Gastric Cancer 1 Shymaa Enany* 1 Department of Microbiology and Immunology, Faculty of Pharmacy, Suez Canal University, Ismailia, Egypt ABSTRACT Key words: H. pylori, Gastric cancer, SabA. Background: Helicobacter pylori (H. pylori) expressed outer membrane proteins (OMPs) that assist in bacterial adherence to the gastric epithelium promoting successful colonization. One of these OMPs is the blood group antigen binding adhesin A (BabA) which bind to the fucosylated Lewisb blood group antigen (Leb) on the surface of gastric epithelial cells. Another OMPs is the sialic acid binding adhesin (SabA) that mediates H. pylori binding the specific sialyl dimeric Lewisx glycosphingolipid (Lex) on the gastric epithelium. A lot of discrepancies about the correlation between the presence of both babA and sabA genes and the apparent clinical outcome of H. pylori infection were reported. Objectives: The present study was to disclose the relationship between the presence of these genes and the clinical outcomes in Egyptian H. pylori patients. Methodology: Forty three H. pylori strains were isolated from patients with different clinical findings. Polymerase chain reaction (PCR) for detecting the presence of babA and sabA genes was performed using different sets of primers for detecting different regions of the gene. Further bioinformatics analysis for the sabA product was done using KEGG and Pfam websites. Results: evincing striking correlation between sabA presence and the gastric cancer disease. However, we could not find any correlation between presence of babA and the associated diseases. Conclusions: SabA is one of the H. pylori OMPs adhesins involving in increasing the risk of H. pylori associated gastric cancer in H. pylori Egyptian patients. INTRODUCTION Outer membrane proteins (OMPs) are expressed in Helicobacter pylori (H. pylori) and are essential for bacterial adherence to the gastric epithelium facilitating its gastric colonization, the establishment of the infection, and the delivery of the virulence factors to the epithelial cells1. The H. pylori OMPs differ significantly from other Gram negative bacteria in having multiple lower abundance OMPs and no major predominate OMPs, however, they are like other Gram negative bacteria OMPs in being consisted of phospholipids and lipopolysaccharide 2,3. They consisted of five major families; the largest family (Family 1) is adhesins, while the other four families are porins, iron transporters, flagellum associated proteins, and proteins with unknown function3. *Corresponding Author: Shymaa Enany Department of Microbiology and Immunology, Faculty of Pharmacy, Suez Canal University, Ismailia, 41522, Egypt. Email: [email protected]. Phone: +201224297176. Egyptian Journal of Medical Microbiology Family 1 consisted of 21 members Hop and 12 members Hor, family 2 comprised 8 Hof, family 3 consisted of 4 Hom, family 4 composed of 6 iron regulated OMPs, and family 5 comprised 3 efflux pump OMPs2. Most expressed H. pylori adhesins which promote specific binding to the host gastric epithelium receptor are included in family 1; Hop members 4. Due to these adhesins, it was found that H. pylori is the most successful bacterium that colonizes the mucus layer of the gastric epithelium with a prevalence of its infection reached up to 100% and around 60% in developing and developed countries; respectively4. These OMPs include the blood group antigen binding adhesin A (BabA), the sialic acid binding adhesin (SabA), the adherence associated lipoproteins A and B (AlpA and AlpB), and the outer inflammatory protein A (OipA). Association of these OMPs with clinical outcomes was variably reported all over the world 5-8. Blood group antigen binding adhesin A (BabA) is the major adhesion in H.pylori that mediates the binding of the bacterium to the fucosylated Lewisb blood group antigen (Leb) on the surface of gastric epithelial cells which is considering the dominant antigen in the gastric mucosa4. Although European researchers previously 35 Enany / The Sialic Acid Binding Adhesin (SabA) of Helicobacter pylori, Volume 24 / No. 4 / October 2015 35-40 indicated that babA gene is of high clinical relevance and would be a useful marker to identify patients who are at higher risk for specific H. pylori related diseases7, Asian group proved that presence of babA is not of high clinical relevance in Japan and that Japanese strains are different from those infecting Western populations 9. The second most characterized adhesion of H. pylori is the sialic acid binding adhesin (SabA) that mediates the binding of the bacterium to the sialyl dimeric Lewisx glycosphingolipid (Lex) expressed on gastric epithelium4. The correlation between the presence of SabA and the related H. pylori diseases is also a matter of controversy. Epidemiological studies showed that in Asia SabA presence has little influence on H. pylori clinical outcomes 10, 11 and in European and North American countries SabA status has close relationship with gastric cancer 12; that inconsistent result is mostly attributed to the mutable geographic variations. Therefore, in this study we investigated the presence of sabA and babA genes in the clinical H. pylori isolates from Ismailia, Egypt and tried to find the correlation between their presence and the clinical outcomes of the patients. METHODOLOGY H. pylori culture Forty three H. pylori strains were selected from our previous master work as following: 10 from normal (N), 10 from gastric ulcer (GU) patients, 10 from duodenal ulcer (DU) patients, 10 from gastritis (G) patients, and 3 from gastric cancer (GC) patients 13. They were isolated from antral biopsy specimens of patients with dyspeptic symptoms and clinically indicated for upper gastrointestinal endoscopy. All endoscopic examinations were carried out using Video endoscope PENTAX EMP-3500. The selected strains were recultured on H. pylori selective ready plates containing trimethoprim, polymyxin B, vancomycin, and amphotericin B (Nissui Pharmaceuticals, Tokyo, Japan) at 37°C in a microaerophilic atmosphere. Single colonies were sub-cultured on 5% sheep blood agar (Becton Dickinson, Tokyo, Japan) and then harvested for storage at −80°C to be ready for subsequent reactions. Detection of urea, sabA, and babA genes by PCR Genomic DNA was extracted from the colonies by boiling method and DNA density was determined by spectrophotometer. The extracted DNA was used for all PCR reactions. Since in our previous study, we confirmed the presence of subunit of H. pylori urease gene (ureA) by PCR in 20 samples out of 150 from them 7 only were included in this study, we performed PCR for detecting ureA gene in all the selected strains including here according to He et al and Enany et al 13,14. Primers used were included in table 1. The presence of sabA and babA in H. pylori clinical isolates was analyzed by PCR using two sets of primer pairs for sabA gene separately and one set for babA gene as listed in table 1. PCR reactions were performed in a final volume of 25 μL containing 12.5μL 2x EmeraldAmp ® PCR Master Mix(Takara, Japan), 500ng from genomic DNA as a template, and 10μ molar from each primer using a thermal cycler (Takara, Japan). PCR amplification was performed under the following condition: an initial denaturation for 5 min at 98°C; 30 cycles of 1min at 98°C, 1min at 60°C, and 1min at 72°C; and a final extension at 72°C for 10min 15 . The resulting PCR product was analyzed on 1.5% agarose gel with ethidium bromide. Table 1: The primers list used in this study Target gene Primer sequence (5`-3`) F-CCCAATGGTAAATTAGTT ureA R-CTCCTTAATTGTTTTTAC F-CCGCTAGTGTCCAGGGTAAC sabA (set 1) R-CGCGCTGTAAGGGTTATTGAAC F-TTTTTGTCAGCTACGCGTTC sabA (set 2) R-ACCGAAGTGATAACGGCTTG F-AATCCAAAAAGGAGAAAAAGTATGAAA babA R-TGTTAGTGATTTCGGTGTAGGACA Analysis of SabA protein pathway The pathway of SabA; the product of the sabA gene was analyzed using the free Kyoto Encyclopedia of Genes and Genomes (KEGG) database (http://www.genome.jp/kegg/). The entry used was exported from the UniProt database (http://www.uniprot.org/uniprot/) for both reviewed 36 PCR product size 411 Reference 1330 16 622 15 833 17 16 (Swiss-Prot); manually annotated and unreviewed (TrEMBL); computationally analyzed with a gene name (ordered locus name) of HPV225_0734. Confirmation of SabA family and domain For confirming the role of SabA protein as one of the OMPs in H. pylori, we detected the protein family and its domains using both CD search of NCBI's interface Egyptian Journal of Medical Microbiology Enany / The Sialic Acid Binding Adhesin (SabA) of Helicobacter pylori, Volume 24 / No. 4 / October 2015 1-8 (http://www.ncbi.nlm.nih.gov/Structure/cdd/wrpsb.cgi) and Pfam database (http://pfam.sanger.ac.uk/) using the previously mentioned exported protein query sequence. RESULTS AND DISCUSSION Forty three strains from normal, peptic ulcer, gastritis, and gastric cancer cases were included in this study. We examined them for the presence of ureA gene and we detected its presence in all the tested strains that showed a clear positive band at 411 bp (Figure 1). Since the fragment of urease A gene was amplified, we confirming that all the included samples in this study were pure H.pylori whereas He et al and Vinette et al reported that ureA gene is conserved and specific to H. pylori 14, 18. Fig. 1: Agarose gel electrophoresis of the PCR amplification of ureA gene. Lane 1: Low molecular weight marker, Lane 2-17: DNA extracted from different H. pylori strains included in this study For the analysis of babA gene, we showed 40 out of 43 positive samples for babA gene (93%). PCR showed a positive band at 833 bp as shown in figure 2. The correlation between the presence of babA gene and the clinical outcomes in our study was shown in table 2. We could not determine any correlation between the babA presence and the associated disease. Its presence was proved in almost all our isolates even in 9 out of 10 with normal findings. Although it has been reported before that the presence of babA gene is associated with sever gastric diseases 7, it is also found that babA could not be used as a biomarker for peptic ulcer and gastric cancer diseases6. Some studies have suggested H. pylori expressing BabA and OipA are associated with an increased risk of peptic ulcer and gastric cancer in European countries 7, 8. Other studies from Brazil and Thailand showed that BabA is not a biomarker for peptic ulcer disease or gastric cancer5,6. These conflicting data about babA and the prediction of the clinical outcomes was attributed to the geographic different origin of the isolated H. pylori strains 1. Fig. 2: Agarose gel electrophoresis of the PCR amplification of babA gene. Lane 1: Low molecular weight marker, Lane 2-17: DNA extracted from different H. pylori strains included in this study Egyptian Journal of Medical Microbiology 37 Enany / The Sialic Acid Binding Adhesin (SabA) of Helicobacter pylori, Volume 24 / No. 4 / October 2015 35-40 On the other hand, we found that sabA gene was associated with the gastric cancer disease in all tested H. pylori isolated from gastric cancer patients using two sets of primers for detecting different regions of sabA gene. PCR showed positive bands corresponding to 1330 bp and 622 bp which are the product sizes of both set 1 and set 2 of sabA gene detecting primers in the group of gastric cancer, while no band appeared by both primers sets in the remaining groups (Figure 3). Fig. 3: Agarose gel electrophoresis of the PCR amplification of sabA gene. (3A): Amplification for sabA1 region; Lane 1: High molecular weight marker, Lane 2-4: DNA extracted from H. pylori strains isolated from gastric cancer patients, Lane 5-17: DNA extracted from H. pylori strains isolated from patients with other different symptoms. (3B): Amplification for sabA2 region. Lane 1: Low molecular weight marker, Lane 2-4: DNA extracted from H. pylori strains isolated from gastric cancer patients. Our results were in accordance with a previous study which showed that sabA binds to the carbohydrate structure Lex antigen expressed on the gastric epithelium and thus associated with an increased gastric cancer risk1. As well, European study provided evidence before that SabA protein may enhance H. pylori pathogenecity in the human gastric epithelium 11. They explained that association by the alteration in the glycosylation patterns in the gastric mucosa during H. pylori infection which in turn promotes bacterial attachment 11. On contrary, in Asia, SabA presence showed no relation with the gastric cancer diseases 10, 11. The prevalence rate of gastric cancer was not statistically different between patients infected with SabA positive and SabA negative H. pylori19. These variations among the relationship between SabA presence and the clinical outcomes again were attributed to the geographical differences. Furthermore, SabA is regulated by phase variation; its expression can rapidly be switched on/off to adapt changes in the gastric media 1 and thus not all strains will produce functional proteins. This will increase the ambiguity about the relationship between the presence of sabA gene and the clinical findings of the patients. Table (2): The prevalence of sabA and babA genes in each clinical group of H. pylori patients. Gene N GU DU G GC 0 0 0 0 3 Positive sabA (set 1) 0 0 0 0 3 Positive sabA (set 2) 9 10 10 8 3 Positive babA Our analysis of the pathways of SabA protein using KEEG revealed that Sab A recognized the sialyl-Lewisx (sLex) which acts as a functional receptor for H. pylori adherence as illustrated in figure 4. It was reported before that H. pylori gastric cancer is associated with the replacement of the non sialylated Lewis antigen by the sialylated Lewis antigen (sLex) 11. One of the chronic inflammatory responses after H. pylori infection is the elevation of the gastric mucosal sialylation, however 38 this level is remaining low either in the healthy or in the individuals after eradication of H. pylori. The identification of sialyl dimeric Lex glycosphinogolipid as a receptor for H. pylori for the first time was reported by a group of researchers in 2002 and they showed that H. pylori infection induced Lex antigen formation in gastric epithelium. They identified this sialyl dimeric Lex binding bacterial adhesion as a 70 K OMP and named it SabA11. Egyptian Journal of Medical Microbiology Enany / The Sialic Acid Binding Adhesin (SabA) of Helicobacter pylori, Volume 24 / No. 4 / October 2015 1-8 Fig. 4: The biological pathway of SabA in H. pylori using Kyoto Encyclopedia of Genes and Genomes (KEGG) database Precise identification of this adhesin was done using the freely available bioinformatics Pfam website. Pfam is a large collection of protein families, each represented by multiple sequence alignments and hidden Markov models (HMMs). It is useful for identifying functionally conserved regions. Our Pfam search results showed that SabA protein was confirmed to be belonged to the family seems confined to Helicobacter. It is predicted to be an outer membrane protein based on its pattern of alternating hydrophobic amino acids similar to porins. It showed Pfam family named HP_OMP. Figure (2) illustrated the arrangement of the Pfam domains that were found on the exported sequence of SabA protein. REFERENCES 1. 2. 3. 4. 5. Fig. 5: Pfam domains arrangements in SabA protein. 6. CONCLUSION We could say that SabA is one of the H. pylori OMPs adhesins involving in increasing H. pylori associated diseases risk. In the Egyptian isolated H. pylori strains there was a strong correlation between the presence of sabA gene and the H. pylori associated gastric cancer and there was no relationship between babA gene existence and the clinical outcomes of H. pylori. Egyptian Journal of Medical Microbiology 7. 8. Wroblewski, L.E., R.M. Peek, Jr., and K.T. Wilson, Helicobacter pylori and gastric cancer: factors that modulate disease risk. Clin Microbiol Rev, 2010. 23(4): p. 713-39. Alm, R.A., et al., Comparative genomics of Helicobacter pylori: analysis of the outer membrane protein families. Infect Immun, 2000. 68(7): p. 4155-68. Kusters, J.G., A.H. van Vliet, and E.J. Kuipers, Pathogenesis of Helicobacter pylori infection. Clin Microbiol Rev, 2006. 19(3): p. 449-90. Oleastro, M. and A. Menard, The Role of Helicobacter pylori Outer Membrane Proteins in Adherence and Pathogenesis. Biology (Basel), 2013. 2(3): p. 1110-34. Chomvarin, C., et al., Prevalence of Helicobacter pylori vacA, cagA, cagE, iceA and babA2 genotypes in Thai dyspeptic patients. Int J Infect Dis, 2008. 12(1): p. 30-6. Gatti, L.L., et al., Prevalence of Helicobacter pylori cagA, iceA and babA2 alleles in Brazilian patients with upper gastrointestinal diseases. Acta Trop, 2006. 100(3): p. 232-40. Gerhard, M., et al., Clinical relevance of the Helicobacter pylori gene for blood-group antigenbinding adhesin. Proc Natl Acad Sci U S A, 1999. 96(22): p. 12778-83. Olfat, F.O., et al., Correlation of the Helicobacter pylori adherence factor BabA with duodenal ulcer disease in four European countries. FEMS Immunol Med Microbiol, 2005. 44(2): p. 151-6. 39 Enany / The Sialic Acid Binding Adhesin (SabA) of Helicobacter pylori, Volume 24 / No. 4 / October 2015 35-40 9. 10. 11. 12. 13. 14. 15. 40 Mizushima, T., et al., Clinical relevance of the babA2 genotype of Helicobacter pylori in Japanese clinical isolates. J Clin Microbiol, 2001. 39(7): p. 2463-5. Yanai, A., et al., Clinical relevance of Helicobacter pylori sabA genotype in Japanese clinical isolates. J Gastroenterol Hepatol, 2007. 22(12): p. 2228-32. Mahdavi, J., et al., Helicobacter pylori SabA adhesin in persistent infection and chronic inflammation. Science, 2002. 297(5581): p. 573-8. Yamaoka, Y., et al., Helicobacter pylori outer membrane proteins and gastroduodenal disease. Gut, 2006. 55(6): p. 775-81. Enany, S.A., S.; Ali, K., The prevalence of h.pylori and resistance patterns in dyspeptic patients from ismailia , Egypt. Suez Canal University Medical Journal, 2005. 8(1): p. 87-92. He, Q., et al., Real-time quantitative PCR for detection of Helicobacter pylori. J Clin Microbiol, 2002. 40(10): p. 3720-8. Hossein Goudarzi , H.R., Mitra Rafizadeh , Afsoon Taghavi, Determination of the Status of Helicobacter pylori sabA Gene in Relation to 16. 17. 18. 19. Clinical Findings. Journal of Medical Bacteriology, 2012. 1(1, 2): p. 3-8. Pakbaz, Z., et al., Frequency of sabA Gene in Helicobacter pylori Strains Isolated From Patients in Tehran, Iran. Iran Red Crescent Med J, 2013. 15(9): p. 767-70. Hajieh Safaei, S.A.H., Hamid Tavakkoli, Morteza Eshaghei, Farahtaj Navabakbar, Rasoul Salehei, Relation of bab A2 genotype of Helicobacter pylori infection with chronic active gastritis, duodenal ulcer and non-cardia active gastritis in Alzahra hospital Isfahan, Iran. Jundishapur Journal of Microbiology, 2010. 3(3): p. 93- 98. Vinette, K.M., et al., Comparison of PCR and clinical laboratory tests for diagnosing H. pylori infection in pediatric patients. BMC Microbiol, 2004. 4: p. 5. Sheu, B.S., et al., Interaction between host gastric Sialyl-Lewis X and H. pylori SabA enhances H. pylori density in patients lacking gastric Lewis B antigen. Am J Gastroenterol, 2006. 101(1): p. 3644. Egyptian Journal of Medical Microbiology